Target Healthcare REIT (LON:THRL – Get Free Report) reached a new 52-week high during trading on Tuesday . The company traded as high as GBX 117 and last traded at GBX 113.40, with a volume of 132837 shares trading hands. The stock had previously closed at GBX 113.36.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of GBX 101.
Check Out Our Latest Research Report on Target Healthcare REIT
Target Healthcare REIT Price Performance
Target Healthcare REIT Company Profile
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Featured Articles
- Five stocks we like better than Target Healthcare REIT
- SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
- Why Rare Earth Processing Could Be the Real 2027 Opportunity
- The S&P 493 Are Staging a Comeback—This Value ETF Offers Broad Exposure
- TSMC Insiders Are Buying the Pullback—But Is the Signal as Bullish as It Looks?
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
